Inventor · disambiguated record
David Jacobs
Also filed as: JACOBS DAVID · JACOBS DAVID S
12 granted patents·1 pending application·210 citations·filing 1991–2023
90Inventor score
Top patents by PatentIndex Score
13 records- 0195US6521216B1Dual phase stannous oral compositionsPROCTER & GAMBLE·Filed 2000·Granted Feb 18, 2003·96 cites·15 claims
- 0291USD341529SPainter's shieldJACOBS DAVID S·Filed 1991·Granted Nov 23, 1993·56 cites·1 claims
- 0387US10898573B1Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2020·Granted Jan 26, 2021·1 cites·30 claims
- 0485US10814001B1Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·2 cites·19 claims
- 0585US2024033250A1Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0682US11701343B2Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·0 cites·28 claims
- 0782US11541036B2Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2022·Granted Jan 3, 2023·0 cites·16 claims
- 0881US10799481B1Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2019·Granted Oct 13, 2020·1 cites·30 claims
- 0979US11311515B2Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·0 cites·29 claims
- 1077US11324722B2Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2021·Granted May 10, 2022·0 cites·23 claims
- 1176US11103482B2Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2021·Granted Aug 31, 2021·0 cites·20 claims
- 1275US10940138B2Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2020·Granted Mar 9, 2021·0 cites·30 claims
- 1374US5859227ARNA sequences which interact with RNA-binding proteinsBEARSDEN BIO INC·Filed 1997·Granted Jan 12, 1999·54 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when David Jacobs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →